Holly Gladstone is a commercial finance and real estate attorney with almost twenty years of experience. Holly represents lenders and borrowers in complex commercial financings in a wide array of industries, including the physical security, pharma and technology services industries.
Holly also has extensive experience handling bilateral and syndicated real estate financings on behalf of borrowers and lenders and maintains an active tenant-side leasing practice. In Holly’s real estate finance practice, she advises clients in connection with mortgage loans, construction loans and New York lien law issues. Some of Holly’s representative real estate financing transactions include:
- Acquisition, bridge and construction loans in excess of $100 million in aggregate for student housing project in Ithaca, New York (counsel to lender)
- Construction loan for hotel redevelopment project in Southeast United States, including negotiation of credit enhancement agreement with hotel franchisor (counsel to agent)
- $75 million acquisition and construction loan for hotel project in Manhattan, including acquisition of air rights (counsel to agent)
- $20 million acquisition and construction loan for mixed use project in western New York, which also involved multiple layers of ground leases with the municipality and the county Industrial Development Authority (counsel to lender)
Holly’s commercial lending practice is primarily focused on senior secured credit facilities, including asset-based loans, middle market loans, and loans with RMR borrowing bases, on both the borrower side and lender side. These representations often involve cross-border debt and complicated intercreditor relationships. Holly also counsels clients in connection with factoring and receivables financings. Holly’s representative commercial lending transactions include:
- $300 million secured revolving and term loan credit facilities for a privately held security alarm company with a private equity sponsor (counsel to agent)
- Term loan and revolving loan financings in excess of $300 million for global pharmaceutical company and its domestic and international subsidiaries (counsel to borrower)
- $200 million asset-based syndicated credit facility for technology services company (counsel to borrower)
- $10 million asset-based credit facility for privately held company in electronic components industry (counsel to lender)
- $30 million receivables purchase facility to a provider of IT services (counsel to seller)
Cost
Rate : $$$
